Literature DB >> 16359470

A case of extended spectrum GEFS+.

Arthur C Grant1, Blanca Vazquez.   

Abstract

A 10-year-old boy developed febrile convulsions at age 2 years, and multiple types of nonfebrile generalized seizures over the ensuing months and years. Gestation, birth, and early development were normal, as were initial EEG and brain imaging studies. By age 5 years, he had developed behavioral difficulties, and the EEG demonstrated both interictal and ictal generalized epileptiform patterns, as well as mild background slowing. Seizures were poorly controlled with multiple medication trials. There was a strong family history of clinically benign febrile seizures in the maternal lineage. Genetic analysis revealed a novel mutation in the voltage-gated neuronal sodium channel SCN1A. This patient's relatively malignant clinical course is consistent with "extended spectrum" generalized epilepsy with febrile seizures plus (GEFS+), and along with the family history illustrates the phenotypic variability of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359470     DOI: 10.1111/j.1528-1167.2005.00357.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

1.  Mutations in SCN3A cause early infantile epileptic encephalopathy.

Authors:  Tariq Zaman; Ingo Helbig; Ivana Babić Božović; Suzanne D DeBrosse; A Christina Bergqvist; Kimberly Wallis; Livija Medne; Aleš Maver; Borut Peterlin; Katherine L Helbig; Xiaohong Zhang; Ethan M Goldberg
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

2.  Protective effect of the ketogenic diet in Scn1a mutant mice.

Authors:  Stacey B B Dutton; Nikki T Sawyer; Franck Kalume; Patricia Jumbo-Lucioni; Karin Borges; William A Catterall; Andrew Escayg
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

3.  Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.

Authors:  Stacey B Dutton; Christopher D Makinson; Ligia A Papale; Anupama Shankar; Bindu Balakrishnan; Kazu Nakazawa; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2012-08-25       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.